VQW-765 for Social Anxiety Disorder
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety Disorder
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 500 (estimated)
- Sponsor
- Vanda Pharmaceuticals · Industry
This trial is looking for adults aged 18-65 with social anxiety disorder. Participants will take a single dose of VQW-765 and will be monitored for effectiveness and safety.
You may be able to join if
- I can provide written consent.
- I am between 18 and 65 years old.
- I have been diagnosed with social anxiety disorder.
- I have a Liebowitz Social Anxiety Scale score of 60 or higher.
- I have a Public Speaking Anxiety Scale score of 60 or higher.
- I have a Hamilton Depression Rating Scale score of 18 or lower.
You may not be able to join if
- I have had a suicide attempt or thoughts in the past 2 years.
- I have a history of bipolar disorder or schizophrenia.
- I have had posttraumatic stress disorder or an eating disorder in the past 6 months.
- I have a substance or alcohol use disorder in the past 6 months.
- I have had psychotherapy in the past 6 months.
- I have taken psychotropic medication in the past 2 months.
- I am currently pregnant or breastfeeding.
- I have any other reason that the investigator thinks means I shouldn't participate.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your EligibilityThis is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a single oral dose of VQW-765 compared to placebo in adults with social anxiety disorder.
Loading trial locations…